Cresco Labs (CRLBF) Other financing activities (2020 - 2026)
Cresco Labs (CRLBF) posted Other financing activities of -$10000.0 for Q1 2026, down 100.24% on a QoQ basis from $4.1 million in Q2 2025, and up 96.89% year-over-year from -$5078.9 in Q1 2025.
Cresco Labs (CRLBF) Other financing activities (2020 - 2026) Analysis & Trends
Cresco Labs' Other financing activities history runs 7 years deep, the most recent figure standing at -$10000.0 for Q1 2026.
- Quarterly Other financing activities rose 96.89% year-over-year to -$10000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.8 million (up 1290.79% YoY) and the FY2025 annual result came in at $11000.0, up 22.22% from the prior year.
- Other financing activities was -$10000.0 for Q1 2026 at Cresco Labs, down from $4.1 million in the prior quarter.
- Across five years, Other financing activities topped out at $4.1 million in Q2 2025 and bottomed at -$4.4 million in Q4 2023.
- A 5-year average of $581250.0 and a median of $395500.0 in 2022 frame the typical range for Other financing activities.
- Peak annual rise in Other financing activities reached 58228.57% in 2025, while the deepest fall reached 16200.0% in 2025.
- Cresco Labs' Other financing activities stood at $218000.0 in 2022, then tumbled by 2095.87% to -$4.4 million in 2023, then surged by 100.16% to $7000.0 in 2024, then jumped by 58228.57% to $4.1 million in 2025, then plunged by 100.24% to -$10000.0 in 2026.
- Business Quant data shows CRLBF's Other financing activities at -$10000.0 in Q1 2026, $4.1 million in Q2 2025, and -$322000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Cresco Labs | 254.96 Mn | 99.57 Mn | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10,000.00 |
| Mar 31, 2026 | -10,000.00 |
| Jun 30, 2025 | 4.08 Mn |
| Jun 30, 2025 | 4.08 Mn |
| Mar 31, 2025 | -322,000.00 |
| Mar 31, 2025 | -322,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | -4.35 Mn |
| Dec 31, 2023 | -4.35 Mn |
| Sep 30, 2023 | 627,000.00 |
| Sep 30, 2023 | 627,000.00 |
| Jun 30, 2023 | 3.10 Mn |
| Jun 30, 2023 | 3.10 Mn |
| Mar 31, 2023 | 624,000.00 |
| Mar 31, 2023 | 624,000.00 |
| Sep 30, 2022 | 218,000.00 |
| Sep 30, 2022 | 218,000.00 |